“This article reinforces investor confidence in biotechnology R&D, with a focus on allocation of financial resources to the Greater Boston Area. The underlying theme; our talent network continues to attract significant investment in start-up, mid, and large-size biotech organizations, giving rise to arguably one of the most competitive job markets in the biosciences industry.” -Chris Tamburrini, Managing Director of AP Biosciences & Healthcare
In this article written by Jeff Engel of www.xconomy.com, he explains the increase in venture capital (VC) investments throughout Boston over the past few years. From 2016-2017, the investments increased nearly 40%.
The 5 largest investments in Boston for 2017 were all bioscience companies. The MassBioEd report for 2017 stated the highest rate of growth has been in the Cambridge and Boston area, all of which these 5 companies are located.
Not only do these investments promise further growth and development within these companies, but they also reflect the overwhelming success each organization has made in 2016 and 2017. The article mentions a concern about the level of investments being made in larger bioscience companies affecting the investments being made into smaller start-ups.
Every company starts small. Investors are astutely assigning financial resources where there’s proven success. As all organizations (small, mid, and large) continue to produce promising data and results, VC’s will continue to invest in their growth.